1. Ministry of Health & Welfare. Cancer pain management guideline 2012;5th ed. Seoul: Ministry of Health & Welfare.
2. Park JM. Korean Society of Anesthesiologists Anesthesiologists. Cancer pain. Anesthesiology & pain medicine 2010;2nd ed. Seoul: Ryo Moon Gak. 379-398.
3. Azevedo Sao Leao Ferreira K, Kimura M, Jacobsen Teixeira M. The WHO analgesic ladder for cancer pain control, twenty years of use. How much pain relief does one get from using it? Support Care Cancer 2006;14:1086-1093.
4. National Comprehensive Cancer Network. NCCN clinical practice guideline in oncology: adult cancer pain 2012;1:Fort Washington: National Comprehensive Cancer Network.
5. American Pain Society Quality of Care Committee. Quality improvement guidelines for the treatment of acute pain and cancer pain. JAMA 1995;274:1874-1880.
6. Yoon DM. Korean Pain Society. Cancer pain. Pain medicine 2007;3rd ed. Seoul: Koonja. 425-442.
7. Harris JT, Suresh Kumar K, Rajagopal MR. Intravenous morphine for rapid control of severe cancer pain. Palliat Med 2003;17:248-256.
8. Portenoy RK. Treatment of cancer pain. Lancet 2011;377:2236-2247.
9. Ripamonti CI, Bandieri E, Roila F. ESMO Guidelines Working Group. Management of cancer pain: ESMO Clinical Practice Guidelines. Ann Oncol 2011;22:Suppl 6. vi69-vi77.
10. Stockler M, Vardy J, Pillai A, Warr D. Acetaminophen (paracetamol) improves pain and well-being in people with advanced cancer already receiving a strong opioid regimen: a randomized, double-blind, placebo-controlled cross-over trial. J Clin Oncol 2004;22:3389-3394.
11. Israel FJ, Parker G, Charles M, Reymond L. Lack of benefit from paracetamol (acetaminophen) for palliative cancer patients requiring high-dose strong opioids: a randomized, double-blind, placebo-controlled, crossover trial. J Pain Symptom Manage 2010;39:548-554.
12. McNicol E, Strassels SA, Goudas L, Lau J, Carr DB. NSAIDS or paracetamol, alone or combined with opioids, for cancer pain. Cochrane Database Syst Rev 2005;1):CD005180.
13. Bruera E, Kim HN. Cancer pain. JAMA 2003;290:2476-2479.
14. Stevens RA, Ghazi SM. Routes of opioid analgesic therapy in the management of cancer pain. Cancer Control 2000;7:132-141.
15. Ripamonti C, Bandieri E. Pain therapy. Crit Rev Oncol Hematol 2009;70:145-159.
16. Foley KM. The treatment of pain in the patient with cancer. CA Cancer J Clin 1986;36:194-215.
17. Kornick CA, Santiago-Palma J, Khojainova N, Primavera LH, Payne R, Manfredi PL. A safe and effective method for converting cancer patients from intravenous to transdermal fentanyl. Cancer 2001;92:3056-3061.
18. Meuser T, Pietruck C, Radbruch L, Stute P, Lehmann KA, Grond S. Symptoms during cancer pain treatment following WHO-guidelines: a longitudinal follow-up study of symptom prevalence, severity and etiology. Pain 2001;93:247-257.
19. McNicol E, Horowicz-Mehler N, Fisk RA, Bennett K, Gialeli-Goudas M, Chew PW, Lau J, Carr D. Americal Pain Society. Management of opioid side effects in cancer-related and chronic noncancer pain: a systematic review. J Pain 2003;4:231-256.
20. Holzer P, Ahmedzai SH, Niederle N, Leyendecker P, Hopp M, Bosse B, Spohr I, Reimer K. Opioid-induced bowel dysfunction in cancer-related pain: causes, consequences, and a novel approach for its management. J Opioid Manag 2009;5:145-151.
21. Stone P, Minton O. European Palliative Care Research collaborative pain guidelines. Central side-effects management: what is the evidence to support best practice in the management of sedation, cognitive impairment and myoclonus? Palliat Med 2011;25:431-441.
22. Tassinari D, Drudi F, Carloni F, Possenti C, Santelmo C, Castellani C. Neuropathic pain in oncology. Novel evidence for clinical practice. Recenti Prog Med 2011;102:220-227.
23. Saarto T, Wiffen PJ. Antidepressants for neuropathic pain: a Cochrane review. J Neurol Neurosurg Psychiatry 2010;81:1372-1373.
24. Wiffen P, Collins S, McQuay H, Carroll D, Jadad A, Moore A. Anticonvulsant drugs for acute and chronic pain. Cochrane Database Syst Rev 2005;3):CD001133.
25. Mercadante SL, Berchovich M, Casuccio A, Fulfaro F, Mangione S. A prospective randomized study of corticosteroids as adjuvant drugs to opioids in advanced cancer patients. Am J Hosp Palliat Care 2007;24:13-19.
26. Vasudev NS, Brown JE. Medical management of metastatic bone disease. Curr Opin Support Palliat Care 2010;4:189-194.
27. Slatkin NE, Rhiner M. Ketamine in the treatment of refractory cancer pain: case report, rationale, and methodology. J Support Oncol 2003;1:287-293.